FDA Warning Letter — RenatiLabs Inc

Case 646353 — FEI 3019300800

The FDA took a Warning Letter action against RenatiLabs Inc on May 31, 2023 (Erlanger, KY). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
RenatiLabs Inc
Date
May 31, 2023
Fiscal Year
2023
Product Type
Biologics
Center
CBER
Location
Erlanger, KY (United States)